| SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer (NCT00002651) | SWOG Cancer Research Network | 1995-05-01 |
| Aberrant Gene Expression Prostate Carcinoma (NCT00868803) | Lahey Clinic | 1995-04-01 |
| Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer (NCT00769548) | Radiation Therapy Oncology Group | 1995-04-01 |
| Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer (NCT00002721) | University of New Mexico | 1995-03-01 |
| Shorter Radiation Schedule for the Treatment of Prostate Cancer (NCT00201916) | Ontario Clinical Oncology Group (OCOG) | 1995-03-01 |
| Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer (NCT00002633) | NCIC Clinical Trials Group | 1995-02-08 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy (NCT00270166) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-02-01 |
| Biological Therapy in Treating Patients With Prostate Cancer (NCT00002637) | Memorial Sloan Kettering Cancer Center | 1995-01-01 |
| Genetic Analysis of Hereditary Prostate Cancer (NCT00001469) | National Human Genome Research Institute (NHGRI) | 1995-01-01 |
| Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer (NCT00846976) | AstraZeneca | 1994-12-01 |
| Prostate Cancer Intervention Versus Observation Trial (PIVOT) (NCT00007644) | VA Office of Research and Development | 1994-11-01 |
| Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00002597) | Radiation Therapy Oncology Group | 1994-10-01 |
| Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00002602) | Radiation Therapy Oncology Group | 1994-05-01 |
| Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer (NCT00959023) | Institute of Cancer Research, United Kingdom | 1993-06-01 |
| Agriculture Health Study (NCT00352924) | National Cancer Institute (NCI) | 1993-04-30 |
| Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer (NCT00769223) | University of California, San Francisco | 1993-02-25 |
| UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies (NCT01737242) | Institute of Cancer Research, United Kingdom | 1993-01-01 |
| Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer (NCT00002511) | European Organisation for Research and Treatment of Cancer - EORTC | 1992-12-01 |
| Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases (NCT00002503) | European Organisation for Research and Treatment of Cancer - EORTC | 1992-10-01 |
| Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate (NCT00548600) | Ontario Clinical Oncology Group (OCOG) | 1992-05-01 |
| Radiation Therapy in Treating Patients With Prostate Cancer (NCT00002480) | Memorial Sloan Kettering Cancer Center | 1991-02-01 |
| Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes (NCT03961217) | Sahlgrenska University Hospital | 1991-01-01 |
| Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520) | Eastern Cooperative Oncology Group | 1990-12-07 |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease (NCT00578240) | Memorial Sloan Kettering Cancer Center | 1990-04-01 |
| Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer (NCT00394511) | National Cancer Institute (NCI) | 1988-08-01 |
| Duke Urology Database and Specimen Bank (NCT00978991) | Duke University | 1988-01-01 |
| Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer (NCT00849082) | European Organisation for Research and Treatment of Cancer - EORTC | 1987-05-01 |
| Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study (NCT03410641) | Oslo University Hospital | 1972-01-15 |
| Active Surveillance for Prostate Cancer With Indolent Features (NCT00421265) | Assaf-Harofeh Medical Center | |
| Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy (NCT00651222) | Prostate Cancer Foundation of Chicago | |
| Botulinum Toxin Injection With Prostate Brachytherapy (NCT00681148) | Emory University | |
| YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer (NCT00050297) | Astellas Pharma Inc | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence (NCT00003858) | Alliance for Clinical Trials in Oncology | |
| Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer (NCT06836648) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval (NCT06751524) | Agenus Inc. | |
| Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program (NCT00035217) | National Center for Research Resources (NCRR) | |
| Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154 (NCT00535834) | National Institutes of Health Clinical Center (CC) | |
| Study of a Polymorphism in Patients With Prostate Cancer (NCT00900185) | National Cancer Institute (NCI) | |
| An Expanded Access Program for AM0010 (Pegilodecakin) (NCT03554434) | Eli Lilly and Company | |
| Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer (NCT05002465) | Dana Mathews | |
| Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer (NCT00992615) | Poitiers University Hospital | |
| Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer (NCT04452136) | Jeanne Link | |
| Expanded Access to NanoPac (NCT03756311) | NanOlogy, LLC | |
| Expanded Access [Ga-68] PSMA-11 PET Imaging (NCT04800068) | Mayo Clinic | |
| Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor (NCT04100694) | Merus B.V. | |
| Facilitating Shared Decisionmaking About Prostate Cancer Screening (NCT00013247) | US Department of Veterans Affairs | |
| Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. (NCT00043212) | Northwest Biotherapeutics | |
| A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA (NCT00006430) | National Center for Research Resources (NCRR) | |
| Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer (NCT00767286) | Radiation Therapy Oncology Group | |
| Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia (NCT00416390) | University of Illinois at Chicago | |
| SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063) | Jonsson Comprehensive Cancer Center | |
| Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography (NCT02531672) | Memorial Sloan Kettering Cancer Center | |
| Tumor RNA Transfected Dendritic Cell Vaccines (NCT00108264) | US Department of Veterans Affairs | |
| MLN8237 for a Subject With Adenocarcinoma of the Prostate (NCT03005262) | The University of Texas Health Science Center at San Antonio | |
| Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer (NCT04377152) | University of California, San Francisco | |
| 18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer (NCT04809584) | Stanford University | |
| Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) (NCT00811031) | M.D. Anderson Cancer Center | |
| Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer (NCT00416325) | University of Illinois at Chicago | |
| A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT (NCT02065323) | Oscar Goodman, Jr. | |
| C11 Sodium Acetate PET/CT Imaging of PCa (NCT02826395) | Jonsson Comprehensive Cancer Center | |
| Open-Label, Randomised Parallel-Group Study (NCT00728533) | Ferring Pharmaceuticals | |
| ALA and Prostate Cancer (NCT00309439) | University of Toronto | |
| A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer (NCT04337099) | Matrix Biomed, Inc. | |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy (NCT00257478) | Astellas Pharma Inc | |
| Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging (NCT04348682) | Jonsson Comprehensive Cancer Center | |
| Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer (NCT00116155) | Cell Genesys | |
| Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan (NCT01777061) | Wendell Yap, MD | |
| Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide (NCT00421694) | University of L'Aquila | |
| Treatment Decision Intervention for Veterans With Prostate Cancer (NCT00012935) | US Department of Veterans Affairs | |